Postbiotics as Mitochondrial Modulators in Inflammatory Bowel Disease: Mechanistic Insights and Therapeutic Potential
Biomolecules · 01.07.2025 · 15 (7) · 954
DOI: 10.3390/biom15070954 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 01.07.2025. Verfasst von Santosh Kumar Prajapati und 4 weiteren Autor:innen. Beteiligte Einrichtung: USF Center for Microbiome Research, Microbiomes Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33602, USA. Hauptthemen laut MEDLINE: Mitochondria, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NHLBI NIH HHS, National Institutes of Health and the National Institute on Aging.
Abstract (Originalsprache)
Postbiotics, which are non-viable microbial derivatives including short-chain fatty acids (SCFAs), microbial peptides, and cell wall components, are emerging as novel therapeutic agents for Inflammatory Bowel Disease (IBD). Unlike probiotics, postbiotics offer a safer, more stable alternative while retaining potent bioactivity. IBD, encompassing Crohn’s disease and ulcerative colitis, is characterized by chronic gastrointestinal inflammation, epithelial barrier dysfunction, and immune dysregulation. Recent evidence links mitochondrial dysfunction marked by impaired energy metabolism, oxidative stress, and apoptosis with the pathogenesis and persistence of IBD. Postbiotics have shown the ability to modulate mitochondrial health through multiple mechanisms. SCFAs such as butyrate serve as primary energy substrates for colonocytes, enhancing mitochondrial respiration and promoting biogenesis. They improve mitochondrial function and boost ATP production. Moreover, postbiotics reduce oxidative damage by regulating antioxidant defenses. These antioxidant actions limit epithelial apoptosis and preserve cellular integrity. In addition, postbiotics regulate mitophagy and help maintain mitochondrial quality and reduce inflammation. Structural components such as lipoteichoic acid and peptidoglycan have been shown to interact with mitochondrial pathways and modulate inflammatory responses. Collectively, this review explores the interplay between mitochondrial dysfunction, IBD, and preventive approach using postbiotics. Understanding the connections with postbiotics could open up new avenues for therapeutic interventions aimed at mitigating IBD severity in people with IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- USF Center for Microbiome Research, Microbiomes Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33602, USA.
- Center of Excellence in Aging and Brain Repair, Department of Neurosurgery and Brain Repair, Morsani College of Medicine, University of South Florida, Tampa, FL 33602, USA.
- Department of Botany, SBN Government PG College, Barwani 451551, India.
- Department of Internal Medicine, Digestive Diseases and Nutrition, Morsani College of Medicine, University of South Florida, Tampa, FL 33602, USA.
ORCID-Profile: Santosh Kumar Prajapati, Dhananjay Yadav, Hariom Yadav
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- National Institutes of Health and the National Institute on Aging
- Ed and Ethel Moore Alzheimer’s Disease Research Program of the Florida Department of Health
Zitieren
APA
Prajapati, S. K., Yadav, D., Katiyar, S., Jain, S., & Yadav, H. (2025). Postbiotics as Mitochondrial Modulators in Inflammatory Bowel Disease: Mechanistic Insights and Therapeutic Potential. Biomolecules, 15(7), 954. https://doi.org/10.3390/biom15070954
Vancouver
Prajapati SK, Yadav D, Katiyar S, Jain S, Yadav H. Postbiotics as Mitochondrial Modulators in Inflammatory Bowel Disease: Mechanistic Insights and Therapeutic Potential. Biomolecules. 2025;15(7):954. doi:10.3390/biom15070954
BibTeX
@article{Prajapati2025,
author = {Prajapati, Santosh Kumar and Yadav, Dhananjay and Katiyar, Shweta and Jain, Shalini and Yadav, Hariom},
title = {Postbiotics as Mitochondrial Modulators in Inflammatory Bowel Disease: Mechanistic Insights and Therapeutic Potential},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {7},
pages = {954},
doi = {10.3390/biom15070954}
}
EUVIMED